Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04083690

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04083690
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04083690. Randomized; double masking; primary purpose treatment. Start 2019-10-11 (actual); primary completion 2023-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients
Acronym
METEOR-CRT
Condition
Heart Failure, Systolic
Intervention (Device)
Reprogramming of CRT Device Settings to Optimal Electrical Synchrony
Lead sponsor
Allina Health System (class: other)

Record details

Record id
cardio:ct-nct04083690
Content hash
5cdae114862333a1b9e9e3dfb6f18873f4c02c12ce139ea80014af1ca74dcf37